Portal or subcutaneous insulin infusion: efficacy and impact on liver inflammation-Reference-Cited by-同舟云学术

Portal or subcutaneous insulin infusion: efficacy and impact on liver inflammation

Published:2015-07-07 Issue:5 Volume:29 Page:488-498
ISSN:0767-3981
Container-title:Fundamental & Clinical Pharmacology
language:en
Short-container-title:Fundam Clin Pharmacol

Author:

Dal Stéphanie¹,Jeandidier Nathalie²,Schaschkow Anaïs¹,Spizzo Anne-Hélène²,Seyfritz Elodie¹,Sookhareea Cynthia¹,Bietiger William¹,Péronet Claude¹,Moreau François²,Pinget Michel²,Maillard Elisa¹,Sigrist Séverine¹

Affiliation:

1. DIATHEC; EA 7294; Centre Européen d'Etude du Diabète; Université de Strasbourg; Fédération de Médecine Translationnelle de Strasbourg; Bld René Leriche Strasbourg 67200 France

2. Structure d'Endocrinologie; Diabète -Nutrition et Addictologie; Pôle NUDE; Hôpitaux Universitaires de Strasbourg (HUS); Strasbourg 67000 France

Funder

Vaincre le Diabète

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/fcp.12129/fullpdf

Reference50 articles.

1. Comparison of intraperitoneal and subcutaneous insulin administration on lipids, apolipoproteins, fuel metabolites, and hormones in type I diabetes mellitus;Selam;Metabolism,1989

2. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus;The Diabetes Control and Complications Trial Research Group.;N. Engl. J. Med.,1993